Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer (Q37198970)
Jump to navigation
Jump to search
scientific article published on 13 April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer |
scientific article published on 13 April 2009 |
Statements
1 reference
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer (English)
1 reference
Michael J Morris
1 reference
Neeta Pandit-Taskar
1 reference
Jorge Carrasquillo
1 reference
Chaitanya R Divgi
1 reference
Susan Slovin
1 reference
William K Kelly
1 reference
Dana Rathkopf
1 reference
Gretchen A Gignac
1 reference
David Solit
1 reference
Lawrence Schwartz
1 reference
Ryan D Stephenson
1 reference
Christina Hong
1 reference
Anthony Delacruz
1 reference
Tracy Curley
1 reference
Glenn Heller
1 reference
Xiaoyu Jia
1 reference
Joseph O'Donoghue
1 reference
Steven Larson
1 reference
Howard I Scher
1 reference
1 reference
Identifiers
1 reference